Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19 | Zendy

Hülya Vatansev | Zendy; Mehmet Ali Karaselek | Zendy; Resül Yılmaz | Zendy; Serkan Küççüktürk | Zendy; Ahmet Topal | Zendy; Şebnem Yosunkaya | Zendy; Adem Küçük | Zendy; Celalettın Vatansev | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of Coagulation with TEG in Patients Diagnosed COVID-19

Author(s) -

Hülya Vatansev,

Mehmet Ali Karaselek,

Resül Yılmaz,

Serkan Küççüktürk,

Ahmet Topal,

Şebnem Yosunkaya,

Adem Küçük,

Celalettın Vatansev

Publication year - 2021

Publication title -

turkish journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.277

H-Index - 27

eISSN - 1303-6165

pISSN - 1300-0144

DOI - 10.3906/sag-2106-379

Subject(s) - medicine , fibrinolysis , coagulopathy , covid-19 , fibrinogen , d dimer , coagulation , thrombosis , gastroenterology , prothrombin time , anesthesia , pathology , disease , infectious disease (medical specialty) , outbreak

A high D-dimer level may indicate the risk of coagulopathy and mortality in COVID-19 patients. T hromboelastography (TEG) is a test that evaluates clot formation and fibrinolysis in real-time, unlike routine coagulation tests. The study aimed to investigate the coagulation process with TEG in patients diagnosed with COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research